Ocean Biomedical, Inc.
Pharmaceutical company · New York, United States · OTC: OCEA
Ocean Biomedical, Inc. is a pharmaceutical company headquartered in New York, United States. Its earliest recorded incorporation is in 2019. Its shares trade on OTC under the ticker OCEA. It has reported private securities offerings to the US SEC, most recently $7.6 million sold in a notice filed in 2023.
Ocean Biomedical at a glance
What does Ocean Biomedical do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $7.6 million sold (2023).
Frequently asked questions about Ocean Biomedical
Where is Ocean Biomedical headquartered?
Ocean Biomedical, Inc. is headquartered in New York, United States.
What does Ocean Biomedical do?
Ocean Biomedical, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Ocean Biomedical a public company?
Yes. Ocean Biomedical, Inc. trades on OTC under the ticker OCEA.
When was Ocean Biomedical founded?
The earliest incorporation on record for Ocean Biomedical, Inc. is in 2019, according to public company registers.
Similar companies
- SchrodingerNew York City, New York, United States
- Pfizer IncNew York City, New York, United States
- Actinium Pharmaceuticals, Inc.New York City, New York, United States
- Rocket Pharmaceuticals, Inc.New York City, New York, United States
- Progenics Pharmaceuticals IncNew York City, New York, United States
- Syndax Pharmaceuticals IncNew York City, New York, United States
- Nuvation Bio Inc.New York City, New York, United States
- Immunic, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences